Chromosome 9, band q34, the location of the proto-oncogene c-abl, is a frequent site of translocations in human myeloid and lymphoid leukemia. The best studied translocation at this locus is the exchange between chromosomes 9 and 22, or the t(9;22), which occurs in chronic myelogenous leukemia (CML). The goal is to study translocations which occur at this site in leukemias other than CML, using the t(i;22) of CML as a model, and the c-abl gene as a reference point.
Our aims are to combine methods of recombinant DNA technology (Southern hybridization, pulsed gel electrophoresis, and molecular cloning), with cytogenetic techniques (gene-localization by chromosomal in-situ hybridization) to analyze chromosomal translocations, and to use this data to clone the translocation break points and to better understand the disease process. Specifically: 1) To analyze a cell line derived from a T-cell leukemia with t(7;9), and to clone the rearranged T-cell receptor genes at the presumed breakpoint on chromosome 7; 2) To determine the location of breakpoints in a lymphoblastic leukemia cell line with t(9;22), so-called Philadelphia-positive acute lymphoblastic leukemia, and to attempt to clone the break points; 3) To analyze the chromosomal breakpoints in t(9;22) in 13 patients with acute lymphoblastic leukemia, to compare these to CML, and to define molecular and clinical subtypes of this disease; 4) To similarly study the t(6;9) in three patients with acute myeloid leukemia; 5) To use the results of these studies, and the DNA sequence obtained, to prepare a detailed map of the c-abl gene and its surrounding locus, using this information to enhance our understanding of the biology of these leukemias and their relationship to c-abl or to other genes that may be involved. These studies should provide a better understanding of the molecular basis of neoplastic transformation in leukemic cells, as well as provide new and interesting information about the detailed structure of c-abl and its chromosomal surroundings. Lastly, the application of these findings in patient samples will have clinically useful diagnostic and prognostic implications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA044700-03
Application #
3458086
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1987-06-01
Project End
1992-05-31
Budget Start
1989-06-01
Budget End
1990-05-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Westbrook, C A (1992) The role of molecular techniques in the clinical management of leukemia. Lessons from the Philadelphia chromosome. Cancer 70:1695-700
Hanish, J; Rebelsky, M; McClelland, M et al. (1991) Application of methylase-limited partial NotI cleavage for a long-range restriction map of the human ABL locus. Genomics 10:681-5
Tkachuk, D C; Westbrook, C A; Andreeff, M et al. (1990) Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 250:559-62
Papadopoulos, P C; Greenstein, A M; Gaffney, R A et al. (1990) Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia. Genes Chromosomes Cancer 1:233-9
Hooberman, A L; Rubin, C M; Barton, K P et al. (1989) Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electrophoresis. Blood 74:1101-7
Hooberman, A L; Carrino, J J; Leibowitz, D et al. (1989) Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 86:4259-63
Kwiatkowski, D J; Westbrook, C A; Bruns, G A et al. (1988) Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet 42:565-72